v3.25.4
Statements of Changes in Stockholders’ Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 230 $ 24,770 $ (361,845) $ (336,845)
Balance (in Shares) at Dec. 31, 2023 2,300,000      
Accretion of common stock subject to redemption to redemption amount (3,511,194) (904,957) (4,416,151)
Sale of 265,000 shares of common stock $ 27 2,649,973 2,650,000
Sale of 265,000 shares of common stock (in Shares) 265,000      
Fair Value of Public Warrants at issuance 207,000 207,000
Fair value of representative shares deferred until IPO $ 12 77,268 77,280
Fair value of representative shares deferred until IPO (in Shares) 120,750      
Fair value of rights included in Public units 621,000 621,000
Allocated value of transaction costs to common stock (68,817) (68,817)
Net income 2,632 2,632
Balance at Dec. 31, 2024 $ 269 (1,264,170) (1,263,901)
Balance (in Shares) at Dec. 31, 2024 2,685,750      
Accretion of common stock subject to redemption to redemption amount (2,176,965) (2,176,965)
Net income 1,652,360 1,652,360
Balance at Dec. 31, 2025 $ 269 $ (1,788,774) $ (1,788,505)
Balance (in Shares) at Dec. 31, 2025 2,685,750